Attached files
| file | filename |
|---|---|
| EX-21.1 - EX-21.1 - Savara Inc | mstx-ex211_9.htm |
| EX-31.1 - EX-31.1 - Savara Inc | mstx-ex311_8.htm |
| EX-32.1 - EX-32.1 - Savara Inc | mstx-ex321_11.htm |
| EX-31.2 - EX-31.2 - Savara Inc | mstx-ex312_10.htm |
| 10-K - 10-K - Savara Inc | mstx-10k_20151231.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (Nos. 333-202960, 333-188870, 333-179989, 333-174203, 333-165691, 333-164177, 333-159376, 333-133824, 333-127857 and 333-117022) and the Registration Statements on Form S-8 (Nos. 333-126551, 333-151903, 333-174940, 333-190376, 333-198046 and 333-206330) of Mast Therapeutics, Inc. of our report dated March 14, 2016 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 10‑K.
/s/ PricewaterhouseCoopers LLP
San Diego, California
March 14, 2016